Literature DB >> 12499191

Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

P D Fey1, B Saïd-Salim, M E Rupp, S H Hinrichs, D J Boxrud, C C Davis, B N Kreiswirth, P M Schlievert.   

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is a growing public health concern that has been associated with pediatric fatalities. It is hypothesized that the evolution of CA-MRSA is a recent event due to the acquisition of mec DNA by previously methicillin-susceptible strains that circulated in the community. This study investigated the genetic relatedness between CA-MRSA, hospital-associated MRSA (HA-MRSA), and nonmenstrual toxic shock syndrome (nmTSS) isolates. Thirty-one of 32 CA-MRSA isolates were highly related as determined by pulsed-field gel electrophoresis and spa typing yet were distinguishable from 32 HA-MRSA strains. The 31 related CA-MRSA isolates produced either staphylococcal enterotoxin B (n = 5) or C (n = 26), and none made TSS toxin 1. All CA-MRSA isolates tested contained a type IV staphylococcal cassette chromosome mec (SCCmec) element. In comparison, none of the HA-MRSA isolates (n = 32) expressed the three superantigens. Antibiotic susceptibility patterns were different between the CA-MRSA and HA-MRSA isolates; CA-MRSA was typically resistant only to beta-lactam antibiotics. Six of twenty-one nmTSS isolates were indistinguishable or highly related to the CA-MRSA isolates. MnCop, an nmTSS isolate obtained in Alabama in 1986, was highly related to the CA-MRSA isolates except that it did not contain an SCCmec element. These data suggest that CA-MRSA strains may represent a new acquisition of SCCmec DNA in a previously susceptible genetic background that was capable of causing nmTSS. CA-MRSA poses a serious health risk not only because it is resistant to the antibiotics of choice for community-acquired staphylococcal infections but also because of its ability to cause nmTSS via superantigen production.

Entities:  

Mesh:

Year:  2003        PMID: 12499191      PMCID: PMC149027          DOI: 10.1128/AAC.47.1.196-203.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  Pathogenicity and resistance islands of staphylococci.

Authors:  R P Novick; P Schlievert; A Ruzin
Journal:  Microbes Infect       Date:  2001-06       Impact factor: 2.700

3.  Molecular genetics of SaPI1--a mobile pathogenicity island in Staphylococcus aureus.

Authors:  A Ruzin; J Lindsay; R P Novick
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

Review 4.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

5.  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-08-20       Impact factor: 17.586

6.  The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements.

Authors:  D C Oliveira; A Tomasz; H de Lencastre
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

7.  Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

Authors:  A V Groom; D H Wolsey; T S Naimi; K Smith; S Johnson; D Boxrud; K A Moore; J E Cheek
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

8.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Authors:  T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

9.  The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.

Authors:  M I Crisóstomo; H Westh; A Tomasz; M Chung; D C Oliveira; H de Lencastre
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 10.  The changing epidemiology of Staphylococcus aureus?

Authors:  H F Chambers
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  114 in total

1.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 2.  Antimicrobial resistance: the example of Staphylococcus aureus.

Authors:  Franklin D Lowy
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA.

Authors:  M Aires de Sousa; H de Lencastre
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Origins of community strains of methicillin-resistant Staphylococcus aureus.

Authors:  Edwin D Charlebois; Françoise Perdreau-Remington; Barry Kreiswirth; David R Bangsberg; Daniel Ciccarone; Binh A Diep; Valerie L Ng; Kimberly Chansky; Brian R Edlin; Brian Edlin; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

5.  A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements.

Authors:  Patrice Francois; Gesuele Renzi; Didier Pittet; Manuela Bento; Daniel Lew; Stephan Harbarth; Pierre Vaudaux; Jacques Schrenzel
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin.

Authors:  Sanjay K Shukla; Mary E Stemper; Srinivas V Ramaswamy; Jennifer M Conradt; Robert Reich; Edward A Graviss; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus.

Authors:  Kanokporn Mongkolrattanothai; Susan Boyle; Trudy V Murphy; Robert S Daum
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Efflux Pumps Might Not Be the Major Drivers of QAC Resistance in Methicillin-Resistant Staphylococcus aureus.

Authors:  Megan C Jennings; Megan E Forman; Stephanie M Duggan; Kevin P C Minbiole; William M Wuest
Journal:  Chembiochem       Date:  2017-06-27       Impact factor: 3.164

9.  Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.

Authors:  Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.

Authors:  María Pilar Trotonda; Yan Q Xiong; Guido Memmi; Arnold S Bayer; Ambrose L Cheung
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.